Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes. Journal Article

Local Library Link: Find It @ Loyola

Authors: Barengolts, E; Green, SJ; Chlipala, GE; Layden, BT; Eisenberg, Y; Priyadarshini, M; Dugas, LR
Article Title: Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes.
Abstract: Gut microbiota and their biomarkers may be associated with obesity. This study evaluated associations of body mass index (BMI) with circulating microbiota biomarkers in African American men (AAM) ( = 75). The main outcomes included fecal microbial community structure (16S rRNA), gut permeability biomarkers (ELISA), and short-chain fatty acids (SCFAs, metabolome analysis). These outcomes were compared between obese and non-obese men, after adjusting for age. The results showed that lipopolysaccharide-binding protein (LBP), the ratio of LBP to CD14 (LBP/CD14), and SCFAs (propionic, butyric, isovaleric) were higher in obese ( = 41, age 58 years, BMI 36 kg/m) versus non-obese ( = 34, age 55 years, BMI 26 kg/m) men. BMI correlated positively with LBP, LBP/CD14 ( 0.05 for both) and SCFAs (propionic, butyric, isovaleric, 0.01 for all). In the regression analysis, LBP, LBP/CD14, propionic and butyric acids were independent determinants of BMI. The study showed for the first time that selected microbiota biomarkers (LBP, LBP/CD14, propionic and butyric acids) together with several other relevant risks explained 39%-47% of BMI variability, emphasizing that factors other than microbiota-related biomarkers could be important. Further research is needed to provide clinical and mechanistic insight into microbiota biomarkers and their utility for diagnostic and therapeutic purposes.
Journal Title: Microorganisms
Publisher: Unknown  
Date Published: 2019